News
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Hims, Keeps and other companies advertise topical finasteride with limited disclosures of side effects.
A new report concludes that mental health apps like Rejoyn and DaylightRx can save money and improve outcomes.
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.
The June 2025 issue of NEJM Catalyst Innovations in Care Delivery shows telemedicine innovations applied to a range of health ...
The trial aims to enroll 40 patients with FGFR alterations across the US, who won't need to travel far to receive care.
These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results